483 Fougera Pharmaceuticals Feb 2011

483 Fougera Pharmaceuticals Feb 2011

Neil Bonzagni FDA, Paul Mouris FDA$119.00 - Available Now

FDA investigators audited the Fougera Pharmaceuticals - Melville, NY, United States facility and issued 17 inspectional observations (via FDA 483) on 09 Feb 2011.

Product details

  • Category: Human Drugs
  • Number of Observations: 17
  • Inspection end: 09 Feb 2011
  • Location: Melville, United States
  • FEI: 2432435
Add To Cart